Cecilia A. Haberzettl, Ph.D. is a Principal in Colonial Technology Development Company and she is also the Founder and President of TechnoMed Strategic Partners, Inc.She has consulted on life sciences related technology development for 7 years.Prior to consulting, Dr. Haberzettl was Asst Director, Product Development, at Centocor preceded by various positions of increasing responsibility with Johnson & Johnson’s diagnostics division, Robert Wood Johnson Medical School, Sandoz, St Barnabas Medical Center and Warner Lambert Research Institute.Dr. Haberzettl served as an ex-officio and internationally elected officer and member of the Board of Directors of the American Association for Clinical Chemistry from 1987 to 1998.She has served as an Executive-in-Residence at the University City Science Center since 2002 and has been a reviewer for the Discovery Channel Young Scientist Challenge (DCYSC) competition since 2000.Dr. Haberzettl received her Ph.D. in BioMedical Sciences from UMDNJ-Robert Wood Johnson Medical School/Rutgers University in 1991.She received her MS and BS degrees from Fairleigh Dickinson University in Biochemistry and Biology respectively.Cecilia’s Associate in Applied Science (A.A.S.) degree in Medical Technology is from Orange County Community College (NY).